Loading...
Loading...
Edwards Lifesciences
Corporation
EW, the global leader in the science of heart
valves and hemodynamic monitoring, today announced that it has
received CE Mark in Europe for its EDWARDS INTUITY Valve System for
use in patients undergoing surgical aortic valve replacement (
AVR).
The system, which consists of a bovine pericardial heart valve and
novel delivery system, facilitates small incision surgery and rapid
valve deployment during AVR procedures. The company plans to begin a
disciplined European launch at centers participating in post-approval
clinical studies.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in